Le Lézard
Classified in: Health
Subject: PLW

H-Source Announces U.S. Patent



VANCOUVER, July 18, 2018 /CNW/ - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that it has received allowance by the U.S Patent and Trademark Office (USPTO) for U.S. Patent Application No. 12/772,019.

"We are pleased the USPTO has allowed our patent, Perishable medical product management systems, perishable medical product management methods, and perishable medical product resale methods. Intellectual property (IP) has been a focus for us from the beginning. Combined with our granted patent in Japan and additional pending applications, we are committed to growing our IP portfolio. Our current allowed and granted patents not only support our existing platform but will also provide us new opportunities to innovate and offer breakthrough healthcare solutions," said Murray Walden, President of H-Source.

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for healthcare members to buy, sell and transfer devices, pharmaceuticals, capital equipment and supplies with each other. Members can conduct secure transactions within Integrated Delivery Networks, complete H-Source marketplace or customize their own group hospitals using H-Source's built-in filters. This private marketplace platform is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

"John Kupice"        
John Kupice
CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

SOURCE H-Source Holdings Ltd.


These press releases may also interest you

at 03:05
SAN DIEGO, Oct. 22, 2018 /PRNewswire-PRWeb/ -- Achieve TMS/TMS Center of Alaska, the nation's largest and most experienced provider of deep TMS (transcranial magnetic simulation) for the treatment of depression is now offering TMS treatment for...

at 03:00
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today the commercial launch of an expanded neurotrophic tropomyosin receptor kinase (NTRK) RNA fusion...

at 03:00
Biohaven Pharmaceutical Holding Company Ltd. , a biotechnology company focused on advancing innovative therapies for neurological diseases, today announced that the first participant was dosed with BHV-3500, a third generation calcitonin gene-related...

at 03:00
OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of its...

at 03:00
High Hampton Holdings Corp. ("High Hampton" or the "Company") is pleased to announce that a new independent director has been appointed to its board to strengthen the Company's leadership with an additional seasoned executive...

at 03:00
NEW YORK, Oct. 22, 2018 /PRNewswire-PRWeb/ -- Manhattan Mental Health Counseling, a psychotherapy private practice in NYC that accepts insurance, has issued a warning about the potential health risks of using - and overusing - social media. There...




News published on 18 july 2018 at 09:00 and distributed by: